Punjab Orders Immediate Recall of 5 Injections Over Safety Concerns
Lahore / National – The Punjab government has ordered the immediate withdrawal of five injectable medicines after laboratory analyses revealed them to be substandard or adulterated, raising serious concerns about patient safety. The directive, issued by the Directorate of Drugs Control on 13 November, compels the Provi
60-Second Editorial Quick Summaryخلاصہ
Verified facts & intelligence briefed by National News Press Bureau.
Lahore / National – The Punjab government has ordered the immediate withdrawal of five injectable medicines after laboratory analyses revealed them to be substandard or adulterated, raising serious concerns about patient safety.
The directive, issued by the Directorate of Drugs Control on 13 November, compels the Provincial Quality Control Board to remove the affected batches from circulation.
The recall covers Injection Dormicum (batches 47447 and 47661) from Martin Dow Marker Ltd., which showed visible particulate matter; Injection Davilax (batch DD1126) from Unison Chemical Works, declared adulterated; Injection Zeftrox (batch 677) from Zafa Pharmaceutical Laboratories (Pvt.) Ltd.; and two batches of Injection PSOL – 2 mL (batch AK164) and 10 mL (batch VL277) – from Pharmasol Private Ltd., both found substandard through sterility testing and particulate inspection.

LAHORE BUREAU —Lahore / National – The Punjab government has ordered the immediate withdrawal of five injectable medicines after laboratory analyses revealed them to be substandard or adulterated, raising serious concerns about patient safety. The directive, issued by the Directorate of Drugs Control on 13 November, compels the Provincial Quality Control Board to remove the affected batches from circulation.
The recall covers Injection Dormicum (batches 47447 and 47661) from Martin Dow Marker Ltd., which showed visible particulate matter; Injection Davilax (batch DD1126) from Unison Chemical Works, declared adulterated; Injection Zeftrox (batch 677) from Zafa Pharmaceutical Laboratories (Pvt.) Ltd.; and two batches of Injection PSOL – 2 mL (batch AK164) and 10 mL (batch VL277) – from Pharmasol Private Ltd., both found substandard through sterility testing and particulate inspection.
The Directorate has instructed manufacturers and marketing authorization holders to retrieve the implicated lots, furnish full distribution records, investigate root causes, and submit Corrective and Preventive Action (CAPA) plans to the relevant authorities. Pharmacies, medical stores, wholesalers, distributors and healthcare facilities across Punjab have been told to cease dispensing the recalled batches and to report remaining inventory and consumption data to Drug Inspectors.
Regulatory bodies are directed to intensify surveillance of the pharmaceutical supply chain and enforce provisions of the Drugs Act, 1976 and the DRAP Act, 2012. Patients are urged to discontinue use of the affected products, as continued administration could pose health risks, and to report any adverse reactions to the Provincial Pharmacovigilance Centre at the Directorate of Drugs Control, Peshawar.
For the public, the recall underscores the importance of vigilance in drug safety and the role of regulatory oversight in protecting health. Consumers should verify batch numbers before use, and healthcare professionals are encouraged to remain alert for potential adverse events linked to these injections, ensuring timely reporting to safeguard community wellbeing.
Key Takeaways & Executive Analysis
- Lahore / National – The Punjab government has ordered the immediate withdrawal of five injectable medicines after laboratory analyses revealed them to be substandard or adulterated, raising serious concerns about patient safety.
- The directive, issued by the Directorate of Drugs Control on 13 November, compels the Provincial Quality Control Board to remove the affected batches from circulation.
- The recall covers Injection Dormicum (batches 47447 and 47661) from Martin Dow Marker Ltd., which showed visible particulate matter; Injection Davilax (batch DD1126) from Unison Chemical Works, declared adulterated; Injection Zeftrox (batch 677) from Zafa Pharmaceutical Laboratories (Pvt.) Ltd.; and two batches of Injection PSOL – 2 mL (batch AK164) and 10 mL (batch VL277) – from Pharmasol Private Ltd., both found substandard through sterility testing and particulate inspection.
Audience Reviews & Discussion
Share your perspective, rate coverage accuracy, and engage with verified readers across Pakistan.
